SANDY, UT, UNITED STATES, December 16, 2025 /EINPresswire.com/ -- SignPath Pharma, Inc., a clinical-stage biotechnology company developing LipoCurc™, a novel ...
Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. Pharmaceutical development company PleoPharma has received a ...
VT3989, a transcriptional enhanced associate domain autopalmitoylation inhibitor, targets the Hippo pathway in mesothelioma treatment. The FDA's fast track designation aims to expedite VT3989's ...
NEW YORK, NY / ACCESS Newswire / August 11, 2025 / New to The Street proudly spotlights its esteemed client, NRx Pharmaceuticals, Inc. (NRXP), which today announced that the U.S. Food and Drug ...
WILMINGTON, Del., Aug. 11, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (NRXP), a clinical-stage biopharmaceutical company, today announced US Food and Drug Administration (FDA) has granted Fast ...